Studies have shown that starting a high-efficacy DMT like Tysabri earlier in the disease course can also lead to less ...

Dr Shiv Saidha of Johns Hopkins University and his patient discuss strategies to convey a new diagnosis of multiple sclerosis and to foster shared decision-making for optimal disease management.

Chad Bolema's life changed the day he learned he had Multiple Sclerosis (MS). Bolema, who was 26 years old at the time, ...

Scientists have come up with an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases.

Updates on therapies for relapsing-remitting MS from ACTRIMS 2025 include the effects of B-cell-depleting agents in minority ...

Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Biogen Inc. ( NASDAQ: BIIB) Stifel 2025 Virtual CNS Forum Conference March 18, 2025 10:15 AM ET Great. Good morning, everybody. Happy to be moderating my annual panel where Priya has to listen to me ...

People who are 75 and older will compose 10% of the total population in the U.S. by 2030, representing a 7.5% increase from ...